LDLR GG:CC and risk for AD
| ApoE4+ subjects | ApoE4– subjects | |||
|---|---|---|---|---|
| Patients | Controls | Patients | Controls | |
| GG:CC | 28 (90.3%) | 3 (9.7%) | 14 (41.2%) | 20 (58.8%) |
| A−:T− | 6 (50%) | 6 (50%) | 11 (44%) | 14 (56%) |
| OR 0.9; 95% CI 0.3 to 2.5; Fisher’s exact test p = 0.83; SP 0.06 | OR = 9.3; 95% CI = 1.8 to 48.2; Fisher’s exact test p = 0.008; SP = 0.98 | |||